Devin Wahlen
Foot & Ankle Surgery · Clovis, NMNPI 1316259930
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (42.6%), food and beverage and education — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Rattan And Associates at 28.6% of the total.
Across 51 payments — averaging $67.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Rattan And Associates$987
- Treace Medical Concepts, Inc.$913
- Arthrex$688
- Stryker$610
- Organogenesis Inc.$110
- Flower Orthopedics Coporation$58
- plus $85 from 3 others
What the payments were for
- Travel & lodging$1,47043%
- Food & beverage$1,01629%
- Education$96528%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Rattan And Associates | 2 | $987 |
| Treace Medical Concepts, Inc. | 17 | $913 |
| Arthrex | 9 | $688 |
| Stryker(2 entities) | 10 | $610 |
| Organogenesis Inc. | 7 | $110 |
| Flower Orthopedics Coporation | 1 | $58 |
| Smith+Nephew | 2 | $52 |
| Orthofix Medical, Inc. | 2 | $18 |
| Avanos Medical | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$527
- ICONIX$412
How this compares
$3,451 in reported general payments places this provider in the 55th percentile of 69 foot & ankle surgery providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 192 | $1,743 |
| Ammonium Lactate | 70 | $1,371 |
| Naloxone Hcl | 16 | $1,245 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 98 | $1,048 |
| Terbinafine Hcl | 48 | $849 |
| Pregabalin | 56 | $569 |
| Ketorolac Tromethamine | 20 | $321 |
| Clindamycin Hcl | 42 | $299 |
| Bupropion Hcl SrBupropion Hcl | 19 | $273 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 37 | $268 |
| Ciprofloxacin Hcl | 32 | $226 |
| Ibuprofen | 12 | $125 |
| Ondansetron Hcl | 25 | $108 |
| Allopurinol | 14 | $62 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Clovis
- Joshua WolfeLas Cruces$55K
- Adam GoughSilver City$44K
- Ruben NunezLas Vegas$31K
- Alexander RamirezLas Vegas$22K
- Harsh AminLas Vegas$18K
- Stephanie GonzalezLas Cruces$15K
- Mark MargiottaAlbuquerque$12K
- Lindsy AllenLas Vegas$10K
- Jason DunnAlbuquerque$10K
- Alexander JenksAlbuquerque$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.